RaQualia Pharma Inc. (4579.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 23.93B |
| Enterprise Value | 23.59B |
| P/E Ratio | 75.87 |
| PEG Ratio | 3.71 |
| Price/Sales Ratio | 4.53 |
| Price/Book Ratio | 2.26 |
| Enterprise/Revenue | 4.05 |
| Enterprise/EBITDA | 18.64 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 3.98B |
| Revenue/Share | 149.87 |
| Gross Profit | 3.27B |
| EBITDA | 985.17M |
| Net Income | 273.12M |
| Diluted EPS | 11.36 |
Balance Sheet
| Total Cash | 4.7B |
| Total Cash/Share | 180.49 |
| Total Debt | 2.69B |
| Total Debt/Equity | 0.34 |
| Current Ratio | 5.78 |
| Book Value Per Share | 300.96 |
Price History
| 52-Week Change | 32.88 |
| 52-Week High | 1,465 |
| 52-Week Low | 438 |
| Moving Average 50 Days | 598.72 |
| Moving Average 200 Days | 673.73 |
Statistics
| Average Volume | 166,578 |
| Shares Outstanding | 26.03M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
